Skip to main content
. 2024 Sep 4;16:1459796. doi: 10.3389/fnagi.2024.1459796

Table 2.

Results of single variant analysis.

Model 1 Model 2
Closest gene Marker dbSNP Reference/effect allele AF OR (95% CI) p value OR (95% CI) p value
Novel loci
AL392172.2 1:222779085 rs4240935 G/T 0.39 1.76 (1.39–2.22) 2.2 × 10−6 1.82 (1.43–2.31) 9.5 × 10−7
AC097655.1 4:60211881 rs11131227 A/C 0.30 0.5 (0.66–0.38) 6 × 10−7 0.51 (0.67–0.38) 1.6 × 10−6
AKR1C2 10:5008180 rs11252881 T/A 0.50 0.54 (0.68–0.42) 2.1 × 10−7 0.56 (0.71–0.44) 1.7 × 10−6
SLC38A1 12:46230329 rs11183403 A/C 0.34 1.78 (1.41–2.25) 1 × 10−6 1.78 (1.41–2.25) 1.7 × 10−6
SCN8A 12:51658428 rs7953996 G/A 0.20 1.98 (2.59–1.51) 6 × 10−7 2.03 (2.67–1.54) 4.1 × 10−7
HAR1A 20:63109757 rs112918561 T/TTG 0.16 2.04 (1.54–2.72) 9.1 × 10−7 2.14 (1.6–2.86) 2.3 × 10−7
AD-Known Loci
RASGEF1C 5:180201150 rs113706587 G/A 0.11 1.41 (1.02–1.96) 0.040 1.43 (1.02–2.01) 0.036
TREM2 6:41161469 rs143332484 C/T 0.008 3.76 (1.58–8.95) 0.003 4.18 (1.74–10.01) 0.001
SEC61G 7:54873635 rs76928645 C/T 0.09 0.62 (0.41–0.94) 0.025 0.64 (0.42–0.99) 0.045
CLU 8:27607795 rs11787077 C/T 0.42 0.76 (0.95–0.61) 0.016 0.78 (0.99–0.62) 0.037
ANK3 10:60025170 rs7068231 G/T 0.46 0.8 (1–0.64) 0.048 0.8 (1.01–0.64) 0.062
SORL1 11:121482368 rs74685827 T/G 0.002 4.64 (1.08–19.86) 0.039 3.16 (0.85–11.78) 0.086
FERMT2 14:52924962 rs17125924 A/G 0.08 1.7 (1.2–2.42) 0.003 1.78 (1.24–2.56) 0.002
PRDM7 16:90103687 rs56407236 G/A 0.05 1.89 (1.18–3.03) 0.008 1.73 (1.07–2.81) 0.026
GRN 17:44352876 rs5848 C/T 0.35 1.28 (1.01–1.62) 0.043 1.28 (1.01–1.63) 0.044
ABCA7 19:1050421 rs115550680 A/G 0.005 3.16 (1.14–8.78) 0.027 3.62 (1.3–10.07) 0.013
APOE 19:44908684 rs429358 T/C 0.13 2.19 (1.64–2.93) 1.3 × 10−7 1.69 (0.29–10) 0.563

Allele frequency (AF) in the table reflects the effect allele frequency in the controls. The AD-Known markers are the same SNPs identified in the AF (Kunkle et al., 2021) and NHW (Bellenguez et al., 2022) GWASs.